Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project
Rafael Marcos‐Gragera(Generalitat de Catalunya), Roberta De Angelis(Istituto Superiore di Sanità), Stefano Ferretti(University of Ferrara), Martine Raphaël(University of Lausanne), Arianna Simonetti(Istituto Superiore di Sanità), Marja‐Liisa Karjalainen‐Lindsberg(University of Helsinki), Carmen Martos(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Pilar Giraldo(Université Paris-Saclay), Carmen Ţereanu(Fondazione IRCCS Istituto Nazionale dei Tumori), T.B. Johannesen(Cancer Registry of Norway), Risto Sankila(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Riccardo Capocaccia(Departamento de Epidemiología), Claudia Allemani(London Cancer), Stefano Luminari(University of Modena and Reggio Emilia), M. Maynadié(Université de Bourgogne)
Cited by 74
Related Papers
The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers
|European Journal of Cancer|2021|650
The causal link between human papillomavirus and invasive cervical cancer: A population‐based case‐control study in colombia and spain
|International Journal of Cancer|1992|576
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555